###### Strengths and limitations of this study

-   This study compares meta-data from different treatments for infantile colic on common outcomes.

-   Guidance and evidence are compared.

-   Distinguishing superiority of treatments is difficult with multiple subpopulations and outcomes.

-   Where aetiology of a condition is uncertain, rationale for treatments are difficult to justify.

-   Effectiveness studies and efficacy studies are needed in this field.

Introduction {#s1}
============

Infantile colic, which is defined as excessive crying in the first few months of life, is a common but poorly understood and often frustrating problem for parents and carers. Infantile colic affects somewhere between 3% and 40% of infants worldwide, depending on geography and definitions used.[@R1] It is estimated that around one in six families (17%) with children consult a health professional about symptoms associated with infantile colic, and these include excessive crying, fussing and distress.[@R2]

Infants cry for various reasons to express discomfort caused by conditions ranging from benign disorders to life-threatening illness. A meta-analysis published in 2017, which included 28 diary studies covering 8690 infants, reported a mean daily fuss and cry duration of 117 min to 133 min in the first 6 weeks of life, followed by a decline in crying time to a mean of 68 min per day by 10 to 12 weeks of age.[@R3] It is suggested that less than 5% of distressed infants have identifiable medical explanations for their crying.[@R4]

There is confusion around the terminology and diagnosis of infantile colic with other diagnostic terms such as silent reflux, functional gastrointestinal disorder and sometimes infantile headache to explain the symptoms of colic. A systematic review of definitions and outcome measures in trials of infantile colic reported the current variability in defining infantile colic, which parallels the non-uniformity of measuring the condition.[@R5] Most definitions are based on Wessel's criteria, also known as the 'rule of threes', which defines colic as paroxysms of irritability, fussing or crying lasting ≥3 hours per day on ≥3 days per week for \>3 weeks[@R6] in an otherwise healthy baby aged 2 weeks to 4 months. However, these criteria have been found to be out of date and impractical to use.[@R7] The most recent diagnostic criteria, formulated by the Rome IV committee, are recurrent and prolonged periods of crying without an obvious cause or evidence of failure to thrive or illness in infants younger than 5 months.[@R8]

The natural history of infantile colic is favourable with symptoms gradually disappearing by the time the infant is 4 months old.[@R9] However, the impact of excessive infant crying on healthcare services is the most common reason for paediatric consultations and hospital emergency department visits in the first weeks of life.[@R10] The consequences of having an excessively crying infant in the family are harmful to relationships and health.[@R11] Excessive infant crying is associated with maternal issues such as depression, anxiety and loss of parenting confidence.[@R12] It is also a common cause of early breastfeeding cessation[@R14] and has been associated with severe infant injury or death as a result of abuse.[@R15]

Recommended management strategies usually centre around parental support and reassurance that the infant is otherwise healthy. However, parents are often in a state of crisis and feel that they want to take action. A number of treatment options exist, which include pharmacological treatments (eg, dicyclomine hydrochloride, cimetropium bromide, simethicone and proton pump inhibitors), probiotics, complementary therapies (including herbal agents and sucrose), manual therapies (for example chiropractic, osteopathy and physiotherapy), dietary interventions and parental behavioural interventions.

Reviews to date have assessed the effectiveness of manipulative therapies,[@R16] probiotics,[@R17] dietary modification,[@R18] complementary and alternative therapies (herbal formulations, sucrose or glucose)[@R19] and pain-relieving agents.[@R19] However, there is limited research which compares these treatments to inform the management of infants experiencing colic and parental decision-making.[@R9]

Aim {#s2}
===

The aim of this study was to review and compare the effectiveness of manual therapy to three of the most common interventions (probiotics, simethicone and proton pump inhibitors) on colic symptoms in infants, including crying time, sleep and infant distress and adverse events.

Methods {#s3}
=======

We conducted a pragmatic narrative systematic review of systematic reviews (SRs) and clinical guidelines for the most common treatments of infantile colic. We employed a review approach using existing analyses of information whether it was based on compiled narrative analyses, meta-analysis or guideline consensus review. A network meta-analyses for comparing outcomes across treatments was not considered as we were aware from the pre-scoping stage of this review that the studies were too heterogeneous in terms of quality between treatment type. The review protocol was registered on the International prospective register of systematic reviews, and this report follows the guidance in the PRISMA statement[@R20] for reporting reviews.

Eligibility criteria {#s3-1}
--------------------

Our population of interest were infants (under 6 months old) with colic as defined by either Wessel's or the ROME III or IV criteria.[@R6] We were not considering infants with diagnosed gastro-oesophageal reflux disease (GORD), as this is considered a pathological condition and differs from colic in that the infants are generally not thriving.

Only children who were otherwise healthy and thriving were included in this study, that is, no other dominant or serious comorbidity requiring medical care in a non-primary care setting.

We considered four treatments for infantile colic: manual therapy, simethicone, proton pump inhibitors and probiotics as these were considered most widely recognised and of interest to the funder. We included the use of proton pump inhibitors because, while it is not recommended for use in infants with colic, it is increasingly being used with these infants to 'rule out' reflux and or GORD, as symptoms of colic are thought to be secondary to GORD.[@R21] Dicyclomine treatment for infantile colic (anti-spasmodic drug) was excluded in this study as it is not recommended for infants under 6 months due to contraindications, mainly respiratory symptoms varying in severity and consequence.[@R22]

We defined manual therapy as any predominantly (more than 75%) touch-based therapy administered by a trained and registered manual therapist, such as a chiropractor, osteopath, osteopathic physician, physical therapist or physiotherapist.

The outcomes of interest were crying time, sleep and parental distress, and in addition, where data existed, adverse events data for each treatment were reviewed.

We limited the type of literature we reviewed to systematic reviews of effectiveness and national clinical guidelines.

We included reviews that reported a systematic review methodology and which had more than one researcher indicated in the review process. Narrative literature reviews and editorials were not included.

We included clinical guidelines where clear methodological procedures for development were reported and included systematically designed evidence reviews and expert panel consensus. The guidance had to be intended for broad use at a national level rather than intended as guidance for a single clinic or hospital or a specific setting. We excluded guidance targeted at parents.

We limited the literature to that published in the last decade between 2009 and 2019 and written in English.

Information sources {#s3-2}
-------------------

For systematic reviews, we searched PubMed, MANTIS, EMBASE, Cochrane and for guidelines we searched those published in English by national organisations. The searches were conducted in June 2019.

Search {#s3-3}
------

Key search terms used were 'systematic reviews', infant\*, colic, 'manual therapy', 'manipulative medicine', simethicone, 'proton pump inhibitors', 'PPIs', probiotics, 'probiotic agents' (see online [supplementary appendix 1](#SP1){ref-type="supplementary-material"}).

10.1136/bmjopen-2019-035405.supp1

We searched the central clearing guideline database and known national guideline centres for guidelines on the treatment, management and care of babies with unsettled or distressed behaviour, including infantile colic.

Study selection {#s3-4}
---------------

Results from searches on each database were downloaded into a Reference Management Software, EndNote (V.X4.0.2), and duplicates were removed; titles and abstracts were screened by two independent researchers. Inclusion/exclusion decisions were made by all three authors. Citation tracking was used to triangulate our searches and check for missing reviews and guidance, as well as to identify other articles that may have not been indexed in PubMed. Full-text papers were obtained for those that met the inclusion criteria and for those where it was unclear whether or not the abstract and title met the inclusion criteria. If a more recent or updated versions of reviews or guidelines were found, the more recent ones replaced those initially found.

Quality appraisal {#s3-5}
-----------------

We appraised the quality of the systematic reviews using a modified version of the AMSTAR 2 critical appraisal tool.[@R23] Of the 15 quality categories assessed, 8 were selected by the authors for the final calculation of quality and we allocated a score of 1 for Yes, 0 for No and 0.5 for Partial Yes. The scale ranged from 0 to 8 (Highest quality). Each study was appraised by two independent reviewers and a third reviewer was used if mitigation was required (see online [supplementary appendix 2](#SP2){ref-type="supplementary-material"}).

10.1136/bmjopen-2019-035405.supp2

We reported on the quality of the guidelines using a modified version of the AGREE II framework.[@R24] The AGREE II checklist has 23 items evaluating six domains. Where more than 75% of the 23 items (\>17/23) were met, we rated these as high-quality guidance. In guidance, where there was insufficient information to record a verdict, we left these domains blank. Guidelines of 16 or less domains did not receive an evaluation of high quality. Each guideline was appraised by one reviewer (see online [supplementary appendix 3](#SP3){ref-type="supplementary-material"}).

10.1136/bmjopen-2019-035405.supp3

Data extraction and items {#s3-6}
-------------------------

We summarised studies by type of intervention, number of studies included, number of participants and outcomes of interest and measure used ([table 1](#T1){ref-type="table"}). We extracted meta-analysed data on hours of crying time and sleeping time between intervention and control groups and other active interventions. For parent distress and confidence, we proposed to compare effect sizes and/or change scores on similar outcomes. In the absence of meta-analysis, change scores or effect size data, we conducted a narrative synthesis of outcomes.

###### 

Characteristics of studies for manual therapy for infantile colic

  Authors                          Participants/n/age/gender                                                                                                  Timing of intervention             Number of studies: type of studies included in review                                                                                      Method of data synthesis (narrative/meta-analysis)
  -------------------------------- -------------------------------------------------------------------------------------------------------------------------- ---------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------
  Alcantara *et al* [@R38]         Infants/n=980 (where reported)/\<18 years/gender not reported                                                              \<4 weeks/30 days                  26: 3 clinical trials, 2 survey studies, 6 case reports, 2 case series, 4 cohort studies, 5 commentaries and 4 reviews of the literature   Narrative
  Carnes *et al* [@R43]            Infants/n=866 (one study not reported)/gender not reported                                                                 8 days to 4 weeks FU 2--11 years   11: 5× RCTs, 1× retrospective review, 2× cohort studies, 3× cases series                                                                   Both
  Clar *et al* [@R39]              Infants/n=not reported                                                                                                     Not reported                       19: 10 SRs and 9 RCTs                                                                                                                      Narrative
  Dobson *et al* [@R16]            Infants/n=358/birth--12 weeks/gender percentages varied (where reported) between 34% and 93% male (mean 56%, median 47%)   8 days to 6 weeks                  6 RCTs                                                                                                                                     Meta-analysis
  Driehuis *et al* [@R42]          Infants/n=283/birth--10 weeks/gender not reported                                                                          8--14 days                         4 RCTs                                                                                                                                     Both
  Ernst[@R41]                      Infants/n=198/2--10 weeks/gender not specified                                                                             8--15 days                         3 RCTs                                                                                                                                     Narrative
  Gleberzon *et al* [@R36]         Infants/n=1459/birth--3 years                                                                                              Immediate---4 weeks                6: 3× RCTs, 1× prospective uncontrolled, 2× retrospective studies                                                                          Narrative
  Parnell Prevost *et al* [@R40]   Infants/n=\>4000/0--12 weeks                                                                                               Not reported                       5: 4 RCTs, 1 obs                                                                                                                           Narrative
  Posadzki and Ernst[@R27]         Infants/n=not reported                                                                                                     Not reported                       2 SRs                                                                                                                                      Narrative
  Posadzki *et al* [@R37]          Infants/n=28/1--12 weeks                                                                                                   28 days                            1 RCT                                                                                                                                      Narrative
  Salehi *et al* [@R28]            Infants/n=368/age=not reported                                                                                             Not reported                       11 SRs---2 SRs for colic                                                                                                                   Narrative

FU, follow-up; RCT, randomised controlled trial; SR, systematic review.

###### 

Characteristics of studies for probiotics for infantile colic

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors                       Participants/n/age/gender                                                    Treatment and timing of intervention                                                         Number of studies: type of studies included in review           Method of data synthesis (narrative/meta-analysis)
  ----------------------------- ---------------------------------------------------------------------------- -------------------------------------------------------------------------------------------- --------------------------------------------------------------- ----------------------------------------------------
  Anabrees *et al* [@R52]       Breastfed or partly breastfed infants/n=209/\<4 months/gender not reported   *L.reuteri* (strains---American Type Culture Collection Strain 55730 and DSM 17938)\         3: 1× Open prospective randomised study, 2× double-blind RCTs   Meta-analysis
                                                                                                             21 days and 28 days                                                                                                                                          

  Batchelor *et al* [@R53]      Infants/n=924/newborns \<3 months (where reported)/gender not reported       *L.reuteri*. 21 days and 90 days (where reported)                                            5: 3× RCTs, 1× observational prospective and 1× meta-analysis   Narrative

  Cruchet *et al* [@R33]        Infants/n=not reported/age not reported/gender not reported                  *L.reuteri*, *B.lactis* and *Str. thermophiles*\                                             9: 1× SR, 8× RCTs                                               Narrative
                                                                                                             Not reported                                                                                                                                                 

  Dryl and Szajewska[@R54]      Infants/n=471/\<6 months/gender not reported                                 *L.reuteri*. 21--30 days                                                                     7 RCTs                                                          Meta-analysis

  Mugambi *et al* [@R25]        Healthy infants                                                              Mixed: synbiotics, probiotics, prebiotics (various strains used). Not reported               25 RCTs                                                         Meta-analysis

  Ong *et al* [@R17]            Infants/n=1886/\<1 month                                                     *L.reuteri* DSM, multistrain probiotics, *L. rhamnosus*, *L. paracasei* and *B. animalis*\   6 RCTs                                                          Meta-analysis
                                                                                                             4/52 before delivery to 6 months                                                                                                                             

  Schreck Bird *et al* [@R55]   Infants/n=444/31--52 days                                                    *L.reuteri* DSM 17938 (10^8^ CFU)\                                                           5 RCTs                                                          Narrative
                                                                                                             21 and 28 days                                                                                                                                               

  Skórka *et al* [@R26]         Infants/4 weeks to 36 months                                                 Various probiotic strains included. 4 weeks to 12 months                                     20 RCTs                                                         Narrative

  Sung *et al* [@R56]           Infants/n=1825/\<3 months                                                    Various strains probiotics. 2 weeks to 6 months                                              12 RCTs                                                         Meta-analysis

  Sung *et al* [@R57]           Infants/n=345/birth to 23 months                                             *L.reuteri* DSM 17938\                                                                       4 RCTs                                                          Meta-analysis
                                                                                                             21 days                                                                                                                                                      
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CFU, colony-forming unit; RCT, randomised controlled trial; SR, systematic review.

###### 

Characteristics of studies for simethicone for infantile colic

  Authors                        Participants/n/age/gender                                                    Timing of intervention                                                                        Number and type of studies included in review   Method of data synthesis (narrative/meta-analysis)
  ------------------------------ ---------------------------------------------------------------------------- --------------------------------------------------------------------------------------------- ----------------------------------------------- ----------------------------------------------------
  Biagioli *et al* [@R19]        Infants/n=167/\<5 weeks/males 45.5%, 44.4%, 49.4%                            7 days                                                                                        4 RCTs                                          Meta-analysis
  Gordon *et al* [@R18]          Infants/n=1121/2--16 weeks/balanced numbers of boys and girls                4--21 days                                                                                    1 RCT                                           Narrative
  Hall *et al* [@R34]            Infants/n=309 (27/32 and 83/92 and 199/267)/2--8 weeks/gender not reported   Not reported                                                                                  3 RCTs                                          Narrative
  Salvatore *et al* [@R29]       1 consensus review, 1 review, 1 SR                                           NA                                                                                            NA                                              Narrative
  Xu *et al* [@R58]              Infants/n=423/3--6 months                                                    *L.reuteri*. 21 and 28 days                                                                   6 RCTs                                          Meta-analysis
  Urbańska and Szajewska[@R59]   Infants/n=838/birth to 26 weeks                                              *L.reuteri*. Up to 1 month for management group and up to 3 months for the prevention group   5 RCTs                                          Meta-analysis

NA, not available; RCT, randomised controlled trial; SR, systematic review.

###### 

Characteristics of studies for proton pump inhibitors for infantile colic

  Authors                             Participants/n/age/gender   Timing of intervention   Number and type of studies included in review   
  ----------------------------------- --------------------------- ------------------------ ----------------------------------------------- -----------
  Gieruszczak-Białek *et al* [@R35]   Infants/n=404/\<12 months   2--4 weeks               5 RCTs                                          Narrative

RCT, randomised controlled trial.

###### 

Characteristics of studies for mixed intervention studies for infantile colic

  Authors                               Intervention                                                        Participants/n/age/gender                               Timing of intervention                                        Number and type of studies included in review                   Method of data synthesis (narrative/meta-analysis)
  ------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------------- --------------------------------------------------------------- ----------------------------------------------------
  Gutiérrez-Castrellón *et al* [@R30]   Probiotics (*L. reuteri*)                                           Infants/n=347/4.1--7.2 weeks/56% female                 21 and 28 days                                                5 RCTs                                                          Meta-analysis
  Manual therapy                        Infants/n=257/5.1--5.9 weeks/56% female                             11--28 days                                             5 RCTs                                                        Meta-analysis                                                   
  Simethicone                           Infants/n=14/4.1 weeks/56% female                                   17 days                                                 1 RCT                                                         Meta-analysis                                                   
  Harb *et al* [@R31]                   Probiotics (*L. reuteri*)                                           Infants less than 6 months old/n=472                    21 and 30 days                                                7: 5 double-blind RCTs, 1 single blind RCT, 1 prospective RCT   Meta-analysis
  Simethicone                           Infants 2 to 8 weeks old/n=193                                      Not reported                                            3 RCTs (simethicone was intervention in 1 and control in 2)   Narrative                                                       
  Lucassen[@R2]                         Manual therapy                                                      Infants/n=not reported/1--9 weeks/gender not reported   10--14 days                                                   1 SR                                                            Narrative
  Probiotics (*L. reuteri*)             Infants/n=126/2--16 weeks/gender not reported                       Not reported                                            1 SR                                                          Narrative                                                       
  Perry *et al* [@R32]                  Probiotics (*L. reuteri*, *L. rhamnosus* and *P. freudenreichii*)   Infants/n=101/0--16 weeks/M=47, F=45                    14 days and 28 days                                           2 RCTs                                                          Narrative
  Manual therapy                        Infants/n=not reported /0--16 weeks/gender not reported             Not reported                                            4 RCTs                                                        Narrative                                                       

RCT, randomised controlled trial; SR, systematic review.

We also extracted adverse event incident data and compared risk ratios between treatments and controls where possible. One researcher extracted characteristics and data from the selected articles, and this was checked by a second researcher. A third reviewer's opinion was sought in cases of disagreement in the extraction process.

Level of evidence {#s3-7}
-----------------

We used reported levels of evidence as published in the reviews and guidance and analysed these to indicate overall level of publication consensus on effectiveness and safety. The strength of the overall evidence was determined by the reviews and guidance evaluated as *Favourable**---***significant benefit to treatment compared with control; *Not favourable---*no significant benefit to treatment compared with control or no difference between treatment and controls; *Unfavourable*---results for treatment worse than control; *Inconclusive---*unable to draw conclusions from results.

Patient and public involvement {#s3-8}
------------------------------

No patient involvement.

Results {#s4}
=======

Study selection {#s4-1}
---------------

We found 201 studies for screening against title and abstract of which 126 were excluded and 75 were selected for full paper review. Of these, a further 43 were excluded and 32 references were finally included in this systematic review. See [figure 1](#F1){ref-type="fig"} flow chart illustrating the process and reasons for exclusion.

![Flowchart of search process for the review. PPI, proton pump inhibitor.](bmjopen-2019-035405f01){#F1}

Eleven studies investigated the effectiveness of manual therapy for treating infantile colic, 12 for probiotics, 1 for proton pump inhibitors, 4 for simethicone and 4 papers which included a combination of the interventions of interest in this review.

The characteristics of the final selection of studies are shown in [tables 1--5](#T1 T2 T3 T4 T5){ref-type="table"} ordered by interventions: manual therapy, simethicone, probiotics, proton pump inhibitors and mixed interventions.

The control arms varied for the studies included in the systematic reviews: for example, in the probiotic, proton pump inhibitors and simethicone studies, the controls were mainly placebos or usual feeding method (mainly breast feeding); and in the manual therapy studies, the controls were either no treatment, usual care, dimethicone and in one craniosacral decompression.

Outcome measures {#s4-2}
----------------

Crying time was the most reported outcome (26/32 studies). In three studies, crying episodes (as opposed to crying duration) were recorded as the outcome measure.[@R18] Three studies did not report outcome data.[@R27]

Fourteen of the 26 papers that reported crying time conducted a meta-analysis. One study[@R30] reported outcomes for all three interventions and another[@R31] reported meta-analysed data for probiotic use and narrative analysis for simethicone. There were 10 meta-analysed results for probiotics, 2 for simethicone and 4 for manual therapy. The data indicated that for breastfed infants, probiotics significantly decreased daily crying time (range −25 min to −65 min). The level of evidence for these findings was reported as high (as indicated by the systematic reviewer authors' appraisal of quality and/or risk of bias) with seven studies reporting high quality, one moderate and two low quality. There were four systematic reviews investigating effectiveness of manual therapy for crying, three showed favourable effects (from −33 min to −76 hours of crying time reduction in 24 hours) and one review was inconclusive. The quality of these randomised controlled trials (RCTs) ranged from moderate to low by the authors of the SRs.

The findings from two studies investigating the effects of simethicone were inconclusive or not favourable and were graded as moderate/low quality. [Table 6](#T6){ref-type="table"} shows the meta-analysed data for crying time.

###### 

Summary of meta-analyses of treatments for infant colic measured by crying time

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                                Time point            24 hours crying time                                                                 Effect           Level of evidence   AMSTAR
  ------------------------------------- --------------------- ------------------------------------------------------------------------------------ ---------------- ------------------- --------
  Probiotics**\***                                                                                                                                                                      

  Ong *et al* [@R17]                    30--90 days           −32.57 min\                                                                          Favourable       Low                 7
                                                              (95% CI −55.6 to −9.54)                                                                                                   

  Dryl and Szajewska[@R54]              21 days and 28 days   −49 min\                                                                             Favourable       High                5.5
                                                              (95% CI −66 to −33) for *L.reuteri* only                                                                                  

  Sung *et al* [@R57]                   21 days               −25.4 min (95% CI −47.3 to −3.5)                                                     Favourable       High                6.5

  Gutiérrez-Castrellón *et al* [@R30]   7--28 days            WMD −51.3 min (95% CI −30.5 to −72.2 min), p=0.0001                                  Favourable       High                7

  Schreck Bird *et al* [@R55]           21 days\              2.3 times more likely to have a ≥50% reduction (p=0.01)                              Favourable       High                6
                                        28 days                                                                                                                                         

  Harb *et al* [@R31]                   21 and 30 days        −55.8 min\                                                                           Favourable       High                8
                                                              (95% CI −64.4 to −47.3)                                                                                                   

  Xu *et al* [@R58]                     14 days\              −42.89 min\                                                                          Favourable       High                7
                                        21 days               (95% CI --60.50 to --25.29; p=0.000)\                                                                                     
                                                              −45.83 min\                                                                                                               
                                                              (95% CI --59.45 to --32.21; p=0.000)                                                                                      

  Urbańska and Szajewska[@R59]          21 days\              −43 min/day\                                                                         Favourable       High                4.5
                                        1 month               (95% CI −68 to −19)                                                                                                       

  Sung *et al* [@R56]                   21 days               −65 min\                                                                             Inconclusive     Low                 8
                                                              (95% CI −86 to −44)                                                                                                       

  Anabrees *et al* [@R52]               21 and 28 days        −56.03 min (95% CI −59.92 to −52.15), RR of 0.06 (95% CI 0.01 to 0.25) NNT 2         Favourable       Moderate            8

  Simethicone                                                                                                                                                                           

  Gutiérrez-Castrellón *et al* [@R30]   7--28 days            WMD −30.0 min (95% CI −20.8 to −39.0 min), p=0.001 for drugs including simethicone   Inconclusive     Moderate            7

  Biagioli *et al* [@R19]               7 days                −0.13 hours\                                                                         Not favourable   Low                 8
                                                              (95% CI −1.40 to 1.14)                                                                                                    

  Manual therapy                                                                                                                                                                        

  Carnes *et al* [@R43]                 1--4 weeks            −1.27 hours\                                                                         Favourable       Moderate            8
                                                              (95% CI −2.19 to −0.36)                                                                                                   

  Gutiérrez-Castrellón *et al* [@R30]   7--28 days            WMD −37.4 min (95% CI −21.5 to −67.0 min), p=0.001                                   Inconclusive     Moderate            7

  Dobson *et al* [@R16]                 8 days to 4 weeks     −1.2 hours\                                                                          Favourable       Low                 8
                                                              (95% CI −1.89 to 0.51)                                                                                                    

  Driehuis *et al* [@R42]               8--10 days            −0.33 hours per day (95% CI −0.012 to 0.59)                                          Favourable       Low                 8
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Predominantly breastfed infants.

NNT, number needed to treat; RR, risk ratio; WMD, weighted mean difference.

There were three studies that reported the number of crying episodes; one was a meta-analysis on the effectiveness of probiotics[@R25] and the other two were narrative analyses, one for probiotics[@R26] and one where simethicone was used as the control arm compared with partially hydrolysed formula.[@R18] The results from these three studies did not support the use of probiotics or simethicone for the treatment of infantile colic and the quality of the studies were reported as low in all studies (see [table 7](#T7){ref-type="table"}).

###### 

Summary of meta-analyses of treatments for infant colic measured by number of crying episodes

  Author                   Intervention   Time point             Number of crying episodes                                                                              Effect                                            Level of evidence   AMSTAR
  ------------------------ -------------- ---------------------- ------------------------------------------------------------------------------------------------------ ------------------------------------------------- ------------------- --------
  Gordon *et al* [@R18]    Simethicone    14 days                3.32 more episodes of crying and fussing with simethicone compared with partially hydrolysed formula   Not favourable c/w partially hydrolysed formula   Very low            8
  Mugambi *et al* [@R25]   Probiotics     Up to 7 months         MD 0.60 (95% CI 0.20 to 1.00) in favour of control for 1 out of 4 studies reported                     Not favourable                                    Low                 8
  Skórka *et al* [@R26]    Probiotics     4 weeks to 36 months   Colic symptoms and crying                                                                              Inconclusive (not favourable)                     Low                 7

MD, mean difference.

Narrative analysis {#s4-3}
------------------

### Crying time {#s4-3-1}

Thirteen of the 26 studies reporting on crying times conducted a narrative review. Two of the studies[@R2] reported on the effectiveness of both probiotics and manual therapy for treating infantile colic. Of the four studies that reported on probiotics, one reported a favourable outcome when compared with simethicone.[@R33] The other studies did not support the use of probiotics and were of low-grade quality.

Two reviews narratively reported on the effects on crying time using simethicone; the findings did not support its use.[@R31] The quality of the studies in these reviews were graded as low by the review authors.

One review reported on crying time, crying episodes, crying time post feeding and parent perception of change in fussing time between infants taking proton pump inhibitors and a placebo. They found no significant differences between groups on any outcome and concluded in the light of associated adverse events unfavourable evidence for the use of proton pump inhibitors.[@R35]

Eight studies reported on the effectiveness of manual therapy for infantile colic. Two studies reported a favourable outcome,[@R36] four were inconclusive,[@R32] one study showed no beneficial effects over the control arm[@R41] and one study reported an unfavourable outcome.[@R2] Most of the reviews for manual therapy graded the RCT studies as low quality.

The findings are summarised in [table 8](#T8){ref-type="table"}.

###### 

Summary of narrative analyses of treatments for infant colic measured by crying time

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                              vs control                                                Time point                           Effect                      Level of evidence                     AMSTAR
  ----------------------------------- --------------------------------------------------------- ------------------------------------ --------------------------- ------------------------------------- --------
  Probiotics                                                                                                                                                                                           

  Batchelor *et al* [@R53]            Not reported                                              21 days and 90 days                  Not favourable              Not reported                          2.5

  Cruchet *et al* [@R33]              Simethicone                                               7, 14 and 21 days                    Favourable                  High prevention, Moderate treatment   4.5

  Lucassen[@R2]                       Placebo                                                   21 days                              Inconclusive                Very Low                              2

  Perry *et al* [@R32]                Placebo and\                                              14 and 28 days                       Inconclusive                Low                                   8
                                      Simethicone                                                                                                                                                      

  Simethicone                                                                                                                                                                                          

  Harb *et al* [@R31]                 Placebo, mint and probiotics                              17--21 days                          Not favourable              Not reported                          8

  Hall *et al* [@R34]                 Placebo                                                   2--8 weeks                           Not favourable              Low                                   4

  Manual therapy                                                                                                                                                                                       

  Alcantara *et al* [@R38]            Dimethicone, no treatment, occipitosacral decompression   14 days and 4 weeks where reported   Inconclusive                Not reported                          5

  Ernst[@R41]                         Not reported                                              8 days to 2 weeks                    Not favourable              Low                                   4.5

  Lucassen[@R2]                       No treatment                                              10--14 days                          Unfavourable                Low                                   2

  Perry *et al* [@R32]                Dimethicone or no treatment                               8 days to 4 weeks                    Inconclusive                Low                                   8

  Clar *et al* [@R39]                 Not reported                                              Not reported                         Inconclusive (favourable)   Low to\                               8
                                                                                                                                                                 moderate                              

  Gleberzon *et al* [@R36]            Not reported                                              \<4 weeks                            Favourable                  Low                                   6

  Parnell Prevost *et al* [@R40]      Not reported                                              Not reported                         Inconclusive                Moderate to high                      7

  Posadzki *et al* [@R37]             Not reported                                              4 weeks                              Favourable\                 Low                                   7
                                                                                                                                     (1 RCT only)                                                      

  Proton pump inhibitors                                                                                                                                                                               

  Gieruszczak-Białek *et al* [@R35]   Placebo                                                   2--4 weeks                           Not favourable              Not reported                          3.5
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

RCT, randomised controlled trial.

Three further narrative studies, two for manual therapy[@R27] and one for simethicone,[@R29] did not report details on how the effectiveness of interventions was measured. The results of these studies were reported as unfavourable or inconclusive and the quality of the studies were low.

Adverse events {#s4-4}
--------------

When reported, there were no serious adverse events reported in the RCTs for either manual therapy, simethicone or probiotics. In one SR,[@R42] four serious adverse events were documented in case studies of manual therapy, including a death, temporary paralysis and a rib fracture, but because these were poorly described and missed underlying pathology could not be ruled out, the overall risk where reported was low. Risks of developing infections with probiotics were reported as extremely low.[@R33] The review on PPIs showed both arms had adverse events, one RCT showed a significant difference between lansoprazole and the placebo for totality of serious adverse effects, mainly lower respiratory tract infections (10/81 vs 2/81, risk ratio 5, 95% CI 1.3 to 20, number needed to harm 11, 95% CI 6 to 49)[@R21] (see online [supplementary appendix 4](#SP4){ref-type="supplementary-material"}).

10.1136/bmjopen-2019-035405.supp4

Guidelines for the treatment, care and management of infants with colic {#s4-5}
-----------------------------------------------------------------------

We found three national clinical guidelines about the treatment and management of 'colicky' infants.

[Table 9](#T9){ref-type="table"} summarises the recommendations they made. The quality rating for the UK guideline development process and reporting met 18/23 criteria, the USA and the Irish guidance 11/23.

###### 

National guideline recommendations infantile colic

  Recommendation/suggestion                                               UK 2013 2017\*   USA 2015†   Ireland 2014‡
  ----------------------------------------------------------------------- ---------------- ----------- ---------------
  Clinician evaluation of mother and baby                                 ✓                ✓           ✓
  Parenting information, advice, support and reassurance                  ✓                ✓           ✓
  Continue breast feeding                                                 ✓                ✓           
  Maternal diet modification                                              ✕                ✓           
  Change formula if formula fed (+unless milk allergy identified)         ✕+               ✓           
  Probiotic supplements (++breastfed-only infants)                        ✕                ✓++         ✓
  Simethicone (eg, infacol)                                               ✕                ✕           
  Herbal supplements (eg, fennel)                                         ✕                ✕           
  Proton pump inhibitors (eg, omeprazole, Losec)                                           ✕           
  Lactase (eg, Co-lief drops)                                             ✕                            
  Anitcholinergic medication (including dicyclomine)                                       ✕           
  Gripe water                                                                              ✕           
  Medicine generally                                                                                   
  Infant massage                                                                                       ✓
  Manual therapy (including spinal manipulation and cranial osteopathy)   ✕                ✕           
  Physical contact (eg, holding, rocking)                                 ✓                            ✓
  White noise                                                             ✓                            
  Bathing                                                                 ✓                            
  Winding                                                                 ✓                            
  Swaddling                                                                                ✕           
  Acupuncture                                                                              ✕           
  Sleep routine                                                                                        

Blank boxes indicate no recommendation or suggestion made not considered or reported. Ticks indicate recommended interventions; cross indicates non-recommended interventions.

\*UK NICE [www.nice.org.uk](www.nice.org.uk) Clinical Knowledge Summary Infant Colic 2017 and *Postnatal care: routine postnatal care of women and their babies* (NICE Guideline, 2015).

†USA 2015 American Academy of Family Physicians (<http://www.aafp.org>).

‡Ireland: Irish College of General Practitioners (<https://www.icgp.ie>).

Discussion {#s5}
==========

Summary of findings and context {#s5-1}
-------------------------------

We found 32 relevant systematic reviews and three examples of guidance. Many of the RCTs were repeated within the reviews and this is reflected by fairly consistent results but differing interpretations. Overall, the meta-analysed results showed that both probiotics in breastfed infants and manual therapy can reduce crying time. The daily reduction in crying is between 33 and 76 min with manual therapy and between 25 min and 65 min with probiotics in breastfed infants. The quality and strength of evidence was higher for probiotics than manual therapy. The evidence for probiotics centred on breastfed infants rather than formula-fed infants and there were a number of different types of strains of probiotics. The manual therapy evidence was based on low to moderate quality RCTs and therefore larger blinded RCTs were recommended. In addition, crying time was reported as the primary outcome in most studies which was used as a proxy indicator of colic resolution or improvement.

There were no serious adverse events reported for either probiotics or manual therapy, indicating that both represent a low risk to infants, although we cannot conclude they are without any risk.[@R27] Two reviews[@R16] analysed the risks of adverse events with manual therapy, one showed 88% less risk of an adverse event in the manual therapy groups than in the control groups[@R43] and the other showed one in six parents reported non-serious adverse events.[@R16] Another study[@R42] reported data from non-RCTs which included four case studies reporting serious incidents of harm but there was some doubt over causality as a result of the treatments given. The risk with probiotic was very low.[@R17]

The data for simethicone and proton pump inhibitors were unfavourable with five reviews concluding either no difference or worsening of symptoms with the use of simethicone. One review concluded no significant differences in crying time or episodes with proton pump inhibitors compared with a placebo, but there was evidence of serious adverse events with the proton pump inhibitor group (one RCT).[@R42] Other older reviews have concluded the same.[@R22]

We found few systematic reviews assessing the effectiveness of PPIs for colic despite their increasing use in this population.[@R21] This is because most studies investigating the use of PPIs were for GORD with symptoms of colic. We are aware, however, of the practice of using PPIs to diagnose GORD by treatment.[@R44] PPIs are designed to suppress acid but have consistently been shown to be ineffective for irritability and fussing in infants with GORD, and they are associated with an increased risk of adverse effects such as infections, allergies and hospital admissions.[@R9] There is evidence from Australia to show that PPIs are being over-prescribed for infants with physiological reflux and symptoms of colic who may or do not have GORD. The reasons are complex, but the authors suggest they centre around inconsistent diagnostic criteria and diagnostic labelling and 'defensive' medicine practice to substantiate the diagnosis with the expectation to medicate.[@R47] None of the guidance reviewed recommended the use of PPIs for the treatment of colic.

We found three nationally representative guidance, and the only other guidance we found was directed at parents with unclear sources of evidence and guidance justification. Clinical evaluation, information, advice, support and reassurance were the only guidance that was agreed in all four guidelines. Three of the four guidelines recommended to continue to breast feed and use physical contact and not to recommend simethicone and manual therapy, despite the difference in current evidence between them, that is, favourable moderate to low quality for manual therapy and unfavourable low quality for simethicone. Despite the stronger evidence for probiotics in breastfed infants, this was only recommended as a treatment to consider in the USA and Irish guidance. The Canadian Paediatric Association issued a position statement in 2012 which was updated in 2019 stating: "*While there may be a role for probiotics in treating infantile colic, there is insufficient evidence to recommend for or against using probiotics to manage this condition"*.[@R48]

Only the USA guidance specifically states not to use proton pump inhibitors for the treatment of colic. We do not know the level of proton pump inhibitors use in the infantile colic population; further research is needed to understand the prescribing practice in this field and the impact on the infants. Conversely, UK NICE guidance development group for the diagnosis and management of GORD stated that: *"it was not unreasonable to offer a trial of either an H~2~RA or a PPI for suspected reflux oesophagitis in infants without endoscopic evidence and that the clinical presentation of reflux oesophagitis would usually be obvious" (NICE 2015*).

Interestingly, the guidance and the evidence do not reflect each other; this may be due to the timing of published evidence and guideline development. The lack of consistent guidance available for parents, pharmacists and clinicians compounds the uncertainty relating to the care of infants with the symptoms of colic.[@R49]

We did not find any evidence around cost-effectiveness analyses of the treatments and there was not enough data to analyse our other outcomes of interest, sleep and parental distress.

Strengths, limitations and challenges {#s5-2}
-------------------------------------

This review was limited to assessing four treatments. The two treatments, probiotics and manual therapy, indicated an effect on reducing crying time. We do not know, however, whether this reduction is meaningful to parents or whether it is sufficient to improve the parent/infant relationship and/or the well-being of the infants, their parents and siblings. We did not compare manual therapy against other therapies such as dietary modification, herbal remedies, white noise, winding, swaddling and baby massage as suggested in some of the guidance. These other remedies and approaches do not appear to have a strong evidence base but are perhaps deemed to be relatively risk free by the expert consensus guidance panels. Although one recent editorial suggests that herbal mixtures and swaddling, while potentially effective, may be harmful because herbal mixtures may affect optimal milk consumption and swaddling may increase hip dysplasia.[@R9] Simethicone and proton pump inhibitors were not considered as risk free and were not recommended in the guidance either explicitly or implicitly.

In addition, it was not always clear what manual treatments were given and how many; therefore, we are unable to comment on type or quantity of manual treatment that may or may not have an effect.

We reviewed data published in the last decade to avoid over-duplication and we only reviewed articles published in English in peer-reviewed journals; this may have introduced some publication bias.

We suspect that the number and diversity of treatments that exist for infantile colic are borne out of desperation and lack of understanding about the aetiology of the colic and its persistence, although self-limiting in most cases. It has also been suggested that this has led to heterogeneous outcomes being measured,[@R11] but several reviews were able to meta-analyse reduction in crying time. None of the reviews measured the well-being or confidence of the parents in managing their infants, or relationships and bonding between the parents and the infants and/or their siblings.

The strength of this review is that we have compared at least two treatments---probiotics and manual therapy---for colic and compared the recommendations in the guidance with the evidence which highlighted the difference in certainty between the evidence and the recommendations. This review found favourable but low to moderate quality evidence for manual therapy. This is different to other reviews, which generally reject manual therapy as an option due to poor quality data. New studies have raised the quality level of data and our more favourable interpretation may, in part, be due to the background of the authors and their understanding that manual therapy is a multicomponent therapy consisting of more than touch alone. The role of the manual therapist to reassure, guide, advise and support parents through this particularly difficult time may also have a therapeutic role to play which may affect parenting and outcomes. More high-quality studies are needed to increase the level of certainty surrounding the findings about the effect of manual therapy for infantile colic.

Future studies should consider the effect of treatment on the parents to explore parenting confidence, parent/infant bonding and meaningful levels of change in crying and sleeping time.

Further research will probably change recommendations in the guidance as the evidence evolves and increases in quality. The guidance we reviewed did not reflect the emerging evidence. Overall, there is uncertainty about the management and care of infants with infantile colic in part due to the lack of consensus surrounding its aetiology and justification for treatments, although increasingly, newer research is providing plausible mechanistic explanations why probiotics may be beneficial due to the presence of gut inflammatory markers.[@R50] Infantile colic is self-limiting in nature and understanding what symptoms and the level of reduction of these symptoms that are important to the infants and their carers needs further investigating. It is understandable that a range of approaches to treatment, management and care exist. Preserving parent choice and balancing this with the limited evidence about effectiveness and safety remains difficult to determine.

Conclusions {#s6}
===========

We found that the strongest evidence for the treatment of infantile colic was probiotics, particularly *Lactobacillus reuteri* for breastfed infants, followed by weaker but favourable evidence for manual therapy indicated by crying time. Both forms of treatment carried a low risk of serious adverse events. Current guidelines will probably change over time in light of existing new and emerging evidence.
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